X0303 4 2010-03-08 0 0001096481 ANGIOTECH PHARMACEUTICALS INC ANPI 0001448731 Gross Jeffrey M 1618 STATION STREET VANCOUVER A1 V6A 1B6 BRITISH COLUMBIA, CANADA 0 1 0 0 SVP, Research & Development Stock Option w/Tandem SAR 1.09 2010-03-08 4 A 0 85000 0 A 2010-04-01 2015-03-07 Common Stock 85000 360000 D The options will start to vest effective 04/01/2010 in equal installments on a monthly basis until 03/01/2014. Represents the number of the Company's shares into which the stock options are convertible. In the event that the Reporting Person elects to exercise the tandem SAR, the stock option will be cancelled and the Reporting Person will be entitled to receive a number of common shares with an aggregate value equal to the product of (a) the excess of the market price of a common share on the date of exercise over the exercise price of the tandem SAR, multiplied by (b) the number of tandem SARs exercised. Price is in Canadian $. /s/David McMasters, Attorney-in-Fact 2010-03-09